COMPLETED

Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease - Eye Tracking

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this research is to determine how removal of little cigar and cigarillo (LCC) flavor descriptors on packaging impacts attention and affective responses to LCC warnings. A study will be conducted using eye tracking, electrodermal activity (galvanic skin response), and survey measures of affect to measure participant responses to LCC packages varied by warning type (pictorial vs. text only) and flavor contents ('Sweet' flavor descriptor vs. no flavor descriptor).

Official Title

Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease - Eye Tracking

Quick Facts

Study Start:2024-08-14
Study Completion:2025-03-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06546618

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Over 21 years old
  2. * Pass quality/bot screening (will answer honestly, captcha, simple math question)
  3. * Speak English
  4. * Current every day or some day users of LCC products
  5. * Able to come to an appointment in NC triangle area
  6. * Do not have any eye conditions that prevent them from being eye tracked (e.g., glaucoma, lazy eye, bifocals)
  1. * Under 21 years old
  2. * Do not speak English
  3. * Unable to pass quality/bot screening
  4. * Unable to come to an appointment
  5. * Eye conditions that prevent eye tracking (e.g., glaucoma, lazy eye, bifocals)

Contacts and Locations

Principal Investigator

Adam O Goldstein
PRINCIPAL_INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center

Study Locations (Sites)

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: UNC Lineberger Comprehensive Cancer Center

  • Adam O Goldstein, PRINCIPAL_INVESTIGATOR, UNC Lineberger Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-14
Study Completion Date2025-03-05

Study Record Updates

Study Start Date2024-08-14
Study Completion Date2025-03-05

Terms related to this study

Keywords Provided by Researchers

  • Text-only warning messages
  • LCC packages with flavor descriptors
  • pictorial warnings messages
  • LCC packages without flavor descriptors

Additional Relevant MeSH Terms

  • Tobacco Use